Nonintubated anesthesia lowers postoperative NLR in thoracoscopic lung cancer resection compared to traditional intubation.
This randomized controlled trial evaluated the effects of nonintubated video-assisted thoracic surgery (NIVATS) versus traditional video-assisted thoracic surgery (VATS) on inflammatory and tumor markers in patients undergoing lung cancer resection. The study included 58 patients (29 per group) at a tertiary medical institution, with outcomes assessed 24 hours postoperatively.
The primary outcome measured the neutrophil-to-lymphocyte ratio (NLR) in peripheral blood. Results indicated that the NLR was significantly lower in the NIVATS group compared to the VATS group (p = 0.031). Additionally, neutrophil percentage was significantly lower in the NIVATS group (p = 0.006), while lymphocyte percentage was significantly higher in the NIVATS group (p = 0.013).
No significant differences were observed between the two groups regarding peripheral blood tumor markers. Safety outcomes included chest air leaks, pneumonia, acute respiratory distress syndrome incidence, new-onset atrial fibrillation, hoarseness, sore throat, and dysphonia. The study did not report specific adverse event rates, serious adverse events, discontinuations, or tolerability data.
Key limitations include the small sample size and the lack of reported funding or conflict of interest information. The study was conducted at a single tertiary institution, which may limit generalizability. While the results suggest a potential reduction in systemic inflammation with nonintubated anesthesia, the evidence is derived from a single trial with incomplete safety reporting.
Clinicians should interpret these findings as preliminary evidence that nonintubated anesthesia may reduce postoperative inflammatory markers in selected lung cancer patients. Further research with larger cohorts and comprehensive safety data is necessary to determine the routine applicability of this technique.